Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly Trevor Williams,

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Elizabeth A. David, MD, David T

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Nathan M. Mollberg, DO, Yalini Vigneswaran, MD, Hedy L

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Chun Chieh Lin, PhD, MBA, Matthew P

Outcomes of Reintervention on the Autograft After Ross Procedure

Joshua E. Rosen, BASc, Hari B

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Jeeyun Lee, MD, Kyoung-Eun.

Double-Lung Transplantation Can Be Safely Performed Using Donors With Heavy Smoking History Sharven Taghavi, MD, MPH, Senthil Jayarajan, MD, Eugene Komaroff,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

James R. Edgerton, MD, Morley A

Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Castigliano M. Bhamidipati, DO, MS, George J

Wickii T. Vigneswaran, MD, Diana Y

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Emanuela Taioli, MD, PhD, Andrea S

Anthony Lemaire, MD, William R

Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Age-Related Outcomes of the Ross Procedure Over 20 Years

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience Pankaj Saxena, FRACS, PhD, James Neal, CCP,

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Dylan R. Nieman, MD, PhD, Christian G. Peyre, MD, Thomas J

Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma David Burkholder,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Bronchoscopic Management of Patients With Symptomatic Airway Stenosis and Prognostic Factors for Survival Lawrence Okiror, MBChB, Li Jiang, MBChB, Nicola.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Characteristics of Malignant Pleural Mesothelioma in Women

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Robert H. Habib, PhD, Thomas A. Schwann, MD, Milo Engoren, MD

Mohammad A. Zafar, MBBS, Emily A

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

William M. Whited, MD, Paul Henley, BS, Erin M

A. Thomas Pezzella, MD, Sari D

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Results of Thoracic Endovascular Aortic Repair 6 Years After United States Food and Drug Administration Approval Asad A. Shah, MD, Michael E. Barfield,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

Cardiac Myxomas: A 50-Year Experience With Resection and Analysis of Risk Factors for Recurrence Ishan K. Shah, MD, Joseph A. Dearani, MD, Richard C.

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Phillip S. Naimo, BS, Matthew S

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Risk of Valve-Related Events After Aortic Valve Repair

Surgical Outcomes of Acute Type A Aortic Dissection in Elderly Patients Kazunori Komatsu, MD, Tamaki Takano, MD, PhD, Takamitsu Terasaki, MD, Yuko Wada,

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly Trevor Williams, MD, MPH, Hadi Duraid, MD, Sydeaka Watson, PhD, Amy Durkin, PA-C, Kristy Todd, PA-C, Hedy L. Kindler, MD, Wickii T. Vigneswaran, MD, MBA The Annals of Thoracic Surgery Volume 100, Issue 5, Pages 1868-1874 (November 2015) DOI: 10.1016/j.athoracsur.2015.04.151 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival curves for patients 70 years and older (blue dashed line) and those younger than 70 years (green solid line). The Annals of Thoracic Surgery 2015 100, 1868-1874DOI: (10.1016/j.athoracsur.2015.04.151) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 The Kaplan-Meier survival curves for patients stratified by (A) epithelioid histology (pure, blue dashed line; mixed, green solid line), (B) adjuvant chemotherapy (with, blue dashed line; none, green solid line), (C) T stage (T1 and T2, green solid line; T3 and T4, blue dashed line), and (D) World Health Organization performance stage (PS 0, green solid line; PS 1 and 2, blue dashed line). The Annals of Thoracic Surgery 2015 100, 1868-1874DOI: (10.1016/j.athoracsur.2015.04.151) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier survival curves stratified by node-positive (N1–N3, blue dashed line) and node-negative (N0, green solid line) status. The Annals of Thoracic Surgery 2015 100, 1868-1874DOI: (10.1016/j.athoracsur.2015.04.151) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Kaplan-Meier survival curves stratified by age and performance status. (Green: age <70 yrs; pre-PS 0, solid line; pre-PS 1, dashed line. Blue: age 70+ yrs; pre-PS 0, long dashed line; pre-PS 1, short dashed line.) The Annals of Thoracic Surgery 2015 100, 1868-1874DOI: (10.1016/j.athoracsur.2015.04.151) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions